https://www.businesswire.com/news/home/20220106005288/en/Anokion-Announces-Progress-Across-Pipeline-of-Novel-Autoimmune-Programs
Anokion Announces Progress Across Pipeline of Novel Autoimmune Programs
Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today reported progress for i...
announcesprogressacrosspipelinenovel
https://www.businesswire.com/news/home/20250108066537/en/Anokion-Announces-Positive-Symptom-Data-from-its-Phase-2-Trial-Evaluating-KAN-101-for-the-Treatment-of-Celiac-Disease
Anokion Announces Positive Symptom Data from its Phase 2 Trial Evaluating KAN-101 for the Treatment...
Anokion SA, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, today announced positive symp...